Ozempic Efficacy Varies Significantly Among Patients, Influenced by Genetics and Eating Behaviors
The effectiveness of GLP-1 prescriptions like Ozempic varies widely among individuals, with some patients losing over 20% of their body weight while others experience minimal or no weight loss. Dr. Anthony Puopolo, Chief Medical Officer at LifeMD, highlights that this disparity is influenced by several factors, including genetic predispositions, eating behaviors, and gender. Research from the 23andMe Research Institute indicates that some individuals lose less than 5% of their body weight or even gain weight, while others achieve substantial reductions. Emotional eating, for instance, is associated with weaker weight loss results compared to external eaters who are primarily influenced by the sight and smell of food. Additionally, individuals with Type 2 diabetes tend to lose less weight than those without the condition, and women generally experience more significant weight loss than men. While genetic variants that blunt GLP-1 drug effects have been identified, a clinically useful pre-treatment genetic t...